cohort,acronym,country,method,unit,blind,mean.fu,mean.age.baseline,n.S,n.NS,mean.TL.baseline.S,sd.TL.baseline.S,mean.TL.baseline.NS,sd.TL.baseline.NS,mean.TL.followup.S,sd.TL.followup.S,mean.TL.followup.NS,sd.TL.followup.NS,mean.attrition.S,sd.attrition.S,mean.attrition.NS,sd.attrition.NS,correlation
ADELAHYDE,ADE,France,TRF,bp,yes,8.249545455,68.25454545,2,42,6290,721.2489168,6378.571429,465.851287,6155,855.5992052,6128.571429,490.8309104,16.44423879,15.55926519,30.01620296,24.19608868,0.917235278
Bogalusa Heart Study,BHS,USA,TRF,bp,no,5.9,31.4,214,421,7392,777,7481,777,7150,772,7270,772,42,46,40,46,0.952819188
"Bruneck study, Italy",BRUNECK,Italy,qPCR,ts,no,10,58.61758,114,307,1.642601,0.8274173,1.676418,0.8395166,1.146818,0.6052806,1.176279,0.5515807,0.0495784,0.0628924,0.0500139,0.0645966,0.6427
Copenhagen City Heart Study,CCHS,Denmark,qPCR,bp,no,9.4,52.7,1402,1455,4318,1047,4434,1062,4042,1010,4116,1031,28,120,33,122,0.39
Caerphilly Cohort Study,CCS,Wales,qPCR,bp,yes,7.984615385,64.41153846,106,154,4302.386792,1591.624522,4506.88961,1867.649925,3438.830189,1472.859658,3080.532468,938.1776116,112.7590184,288.7084378,183.0572872,261.032489,0.032763832
Dunedin Multidisciplinary Health and Development Study,DMHDS,New Zealand,qPCR,ts,yes,12,26,173,458,1.165,0.372,1.199,0.411,1.016,0.314,1.047,0.31,0.0124,0.0245,0.0126,0.0256,0.6646
ERA,ERA,France,TRF,bp,no,9.454482759,59.75862069,1,86,5860,0,6428.837209,620.0254617,5710,0,6198.255814,601.173738,16.04278075,0,24.34415502,15.51546626,0.970648826
"Epidemiological Study on the Chances of Prevention, Early Recognition, and Optimised Treatment of Chronic Diseases in the Older Population",ESTHER,Germany,qPCR,bp,no,8,61.3,116,483,5940,384.49,6020,315.18,5190,522.04,5810,616.72,1.3,84.35,14.5,99.8,NA
Hertfordshire Ageing Study,HAS,England,qPCR,bp,yes,9.267356017,67.08778403,20,87,5490.261096,1464.641745,5417.454118,1443.864092,3637.147308,1539.880245,4048.201005,1446.61579,204.7393379,265.9196871,149.0405518,236.0093555,-0.163755014
Heart and Soul Study,HSS,USA,qPCR,bp,no,4.8,66.1,76,475,5546.32,543.21,5483.28,527.85,5325.56,406.29,5277.76,344.28,46.12,119.89,42.05,102.77,0.397
Jerusalem LRC Study,JLRCS,Israel,TRF,bp,yes,13.06,30.11,154,275,7253,650,7361,673,6907,590,7053,644,26.5,14,23.5,13.6,0.962
Lothian Birth Cohort 1921,LBC1921,Scotland,qPCR,bp,yes,9.143055315,80.2261141,3,76,3912.372295,301.0484383,4096.438208,457.9570472,3290.002217,770.8777979,3542.612191,791.4630346,49.63789869,33.0794223,64.33525186,138.9654593,0.347791835
Lothian Birth Cohort 1936,LBC1936,Scotland,qPCR,bp,yes,6.003026578,69.57495024,62,406,4073.339444,579.0718422,4207.335086,571.3267519,3680.80978,648.0757358,3805.031724,708.3596024,86.94395509,119.9515086,66.38224048,112.1362933,0.544022128
Danish MONICA1 and 10 survey,MONICA,Denmark,qPCR,ts,no,10.92,44.12,532,603,0.7548,0.1581,0.7413,0.1635,0.6542,0.1911,0.6722,0.1976,0.0092,0.0178,0.0063,0.0192,0.3684
Netherlands Study of Depression and Anxiety (NESDA),NESDA,Netherlands,qPCR,bp,no,6,40.76,455,489,5407.29,623.56,5511.6,614.67,5370.51,403.03,5440.66,446.86,6.13,96.55,11.82,95.26,0.447
National Survey of Health and Development,NSHD,England,qPCR,bp,yes,9.303082192,53.43398021,112,326,5610.810025,2017.467288,5792.408872,1827.705814,4241.114337,1236.593017,4297.163475,1345.07619,148.6086658,235.8769375,160.1380221,234.6129257,0.122622422
Prevention of renal and vascular end stage disease,PREVEND,Netherlands,qPCR,ts,no,6.51236,46.59482,1091,1456,1.047737,0.3155769,1.094782,0.3187746,1.000717,0.3625516,1.069063,0.3520621,0.0070087,0.0726895,0.0039228,0.0677521,0.1336
Swedish Adoption/Twin Study of Aging,SATSA,Sweden,qPCR,ts,yes,9.35,66.7,45,302,0.733,0.19,0.731,0.22,0.719,0.15,0.735,0.17,0.002,0.032,-0.002,0.034,0.39